据美国联邦公报消息,2月24日美国食品药品管理局发布条例称,鉴于部分兽药已经停产或者市场已无售,撤销林可霉素、维及霉素、泰乐菌素等20种抗生素类兽药的许可。新规定自2017年2月24号实施。
本次撤销的许可为18种新兽药申请许可(NADAs),以及2种简式新兽药申请许可(ANADAs)。20种兽药均为人畜共用抗生素。
新条例的发布与FDA兽药中心一直倡导的合理使用抗生素的原则一脉相承。
部分原文报道如下:
The Food and Drug Administration (FDA) is withdrawing approval of 18 new animal drug applications (NADAs) and 2 abbreviated new animal drug applications (ANADAs)。 These withdrawals of approval of NADAs and ANADAs for antimicrobial drugs of importance to human medicine that are administered to food-producing animals in medicated feed are being made because the products are no longer manufactured or marketed. These actions are consistent with the FDA Center for Veterinary Medicine's initiative for the Judicious Use of Antimicrobials.
原文链接:https://www.federalregister.gov/documents/2017/02/24/2017-03595/new-animal-drugs-withdrawal-of-approval-of-new-animal-drug-applications